39.77
+2.78(+7.52%)
Currency In USD
| Previous Close | 36.99 |
| Open | 38.8 |
| Day High | 41.25 |
| Day Low | 38.25 |
| 52-Week High | 59.23 |
| 52-Week Low | 20.85 |
| Volume | 779,442 |
| Average Volume | 502,845 |
| Market Cap | 1.47B |
| PE | -142.04 |
| EPS | -0.28 |
| Moving Average 50 Days | 35.29 |
| Moving Average 200 Days | 31.51 |
| Change | 2.78 |
If you invested $1000 in Harrow Health, Inc. (HROW) 10 years ago, it would be worth $5,171.65 as of September 08, 2025 at a share price of $39.77. Whereas If you bought $1000 worth of Harrow Health, Inc. (HROW) shares 5 years ago, it would be worth $6,044.07 as of September 08, 2025 at a share price of $39.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
GlobeNewswire Inc.
7 hours ago
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggre
Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
Announces Commitment for New $40 Million Revolving Credit Facility Issues Conditional Notice of Redemption of 11.875% Senior Notes due 2027 NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference
GlobeNewswire Inc.
Aug 06, 2025 11:00 AM GMT
NASHVILLE, Tenn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in H.C. Wainwright’s 5th Annual Ophthalmology Conference on Wednesd